Vimarsana
Biggest News Aggregation in the World

Page 13 - Submit Comments News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Submit Comments. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Submit Comments Today - Breaking & Trending Today

Other Barks & Bites for Friday, June 16: Republican Senators Introduce No Free TRIPS Bill, Synopsys Wins Trade Secrets Case at Fourth Circuit and Second VLSI Patent Nixed by PTAB - IPWatchdog.com - Vimarsana News

Other Barks & Bites for Friday, June 16: Republican Senators Introduce No Free TRIPS Bill, Synopsys Wins Trade Secrets Case at Fourth Circuit and Second VLSI Patent Nixed by PTAB - IPWatchdog.com

This week in Other Barks & Bites: Music publishers launch a copyright infringement lawsuit against Twitter; Korean authorities arrest a former executive for attempting to replicate a copy of a semiconductor manufacturing facility; three Republican senators introduce a bill attempting to tie President Biden’s hands on TRIPS waivers; and the U.S. Court of Appeals for the Fourth Circuit vindicates Synopsys…

Draft Guidance for Industry: Insanitary Conditions in the Preparation, Packing, and Holding of Tattoo Inks and the Risk of Microbial Contamination - Vimarsana News

Draft Guidance for Industry: Insanitary Conditions in the Preparation, Packing, and Holding of Tattoo Inks and the Risk of Microbial Contamination

FDA is issuing this guidance to help tattoo ink manufacturers and distributors recognize situations in which a tattoo ink may become contaminated with microorganisms, and thus, be potentially injurious to health.

Source: fda.gov
CVM GFI #279 Demonstrating Bioequivalence for Type A Medicated Articles Containing Active Pharmaceutical Ingredient(s) Considered to be Poorly Soluble in Aqueous Media, That Exhibit Little to No Systemic Bioavailability, and Are Locally Acting - Vimarsana News

CVM GFI #279 Demonstrating Bioequivalence for Type A Medicated Articles Containing Active Pharmaceutical Ingredient(s) Considered to be Poorly Soluble in Aqueous Media, That Exhibit Little to No Systemic Bioavailability, and Are Locally Acting

This guidance describes an approach to show bioequivalence for generic Type A medicated articles containing poorly soluble, locally acting, APIs that have little to no systemic absorption, and for which blood level studies are not considered appropriate to demonstrate bioequivalence.

Source: fda.gov
E6(R3) GOOD CLINICAL PRACTICE (GCP) - Vimarsana News

E6(R3) GOOD CLINICAL PRACTICE (GCP)

E6(R3) GOOD CLINICAL PRACTICE (GCP)

Source: fda.gov
Interstitial Cystitis/Bladder Pain Syndrome: Establishing Drug Development Programs for Treatment - Vimarsana News

Interstitial Cystitis/Bladder Pain Syndrome: Establishing Drug Development Programs for Treatment

Draft Guidance Clinical / Medical

Source: fda.gov